1. Home
  2. R vs BLTE Comparison

R vs BLTE Comparison

Compare R & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryder System Inc.

R

Ryder System Inc.

HOLD

Current Price

$190.04

Market Cap

6.5B

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$154.83

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
R
BLTE
Founded
1933
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
6.5B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
R
BLTE
Price
$190.04
$154.83
Analyst Decision
Buy
Strong Buy
Analyst Count
10
8
Target Price
$214.44
$181.14
AVG Volume (30 Days)
281.8K
163.7K
Earning Date
04-22-2026
03-02-2026
Dividend Yield
1.89%
N/A
EPS Growth
7.96
N/A
EPS
11.94
N/A
Revenue
$12,665,000,000.00
N/A
Revenue This Year
$3.91
N/A
Revenue Next Year
$5.74
$363.39
P/E Ratio
$16.15
N/A
Revenue Growth
0.23
N/A
52 Week Low
$125.54
$49.00
52 Week High
$230.39
$200.00

Technical Indicators

Market Signals
Indicator
R
BLTE
Relative Strength Index (RSI) 37.82 34.46
Support Level $184.78 $148.78
Resistance Level $197.80 $161.28
Average True Range (ATR) 5.84 8.38
MACD -1.98 -2.66
Stochastic Oscillator 17.71 6.16

Price Performance

Historical Comparison
R
BLTE

About R Ryder System Inc.

Ryder System Inc operates in three business segments: (1) Fleet Management Solutions which provides full-service leasing and leasing with flexible maintenance options, commercial rental and maintenance services of trucks, tractors and trailers to customers; (2) Supply Chain Solutions (SCS), which provides integrated logistics solutions, including distribution management, dedicated transportation, transportation management, brokerage, e-commerce, last mile, and professional services; and (3) Dedicated Transportation Solutions (DTS), which provides turnkey transportation solutions in the U.S., including dedicated vehicles, professional drivers, management, and administrative support.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: